Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 6/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.34 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16484264 | 0.94 | GRM5 (0.41) | HTR1AHTR7GRM5MCL1DHFR | |
| SCHEMBL17109006 | 0.92 | GRM5 (0.42) | HTR1AHTR7GRM5KDM4EATM | |
| SCHEMBL9955519 | 0.88 | HTR1A (0.43) | HTR1AHTR7GRM5KDM4EATM | |
| SCHEMBL21453997 | 0.87 | L3MBTL1 (0.42) | GRM5KDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL16485710 | 0.87 | KDM4E (0.45) | KDM4EATML3MBTL1ALDH1A1TSHR | |
| SCHEMBL17109004 | 0.86 | HTR1A (0.33) | HTR1AHTR7GRM5 | |
| SCHEMBL17248289 | 0.86 | HTR1A (0.47) | HTR1AHTR7GRM5KDM4EATM | |
| SCHEMBL15857153 | 0.85 | HTR1A (0.36) | HTR1AHTR7GRM5KDM4EATM | |
| SCHEMBL16484272 | 0.85 | KDM4E (0.42) | KDM4EATML3MBTL1ALDH1A1TSHR | |
| SCHEMBL17108998 | 0.85 | KDM4E (0.33) | KDM4EATML3MBTL1MCL1MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9960364-B2 | Ladder compound, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-9960364-B2 | Ladder compound, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-20150270496-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMIITSU KOSAN CO., LTD. (JP) | 2015-09-24 | — | — | US | disclosed |
| US-20150270496-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMIITSU KOSAN CO., LTD. (JP) | 2015-09-24 | — | — | US | disclosed |
| WO-2014057684-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | 出光興産株式会社 (JP) | 2014-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150270496-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | YBX1, ATXN2L, ATXN2 | HTR1A 1317/4885HTR7 2019/4885GRM5 2345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.